Dual role of citrate in mammalian urine

Current Opinion in Nephrology and Hypertension

Volumn 15, Issue 4, 2006, Pages 419-424

  Moe, Orson W ^a   Preisig, Patricia A ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; CITRIC ACID;

CALCIUM EXCRETION; CALCIUM URINE LEVEL; HUMAN; LIFESTYLE; NEPHROLITHIASIS; NONHUMAN; PHOSPHATE EXCRETION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; STONE FORMATION; URINALYSIS; URINARY EXCRETION; URINE; URINE PH;

ANIMALS; CALCIUM; CITRIC ACID; HUMANS; MAMMALS; SPECIES SPECIFICITY;

EID: 33748061953     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mnh.0000232882.35469.72     Document Type: Review

References (21)

1. Davids MR, Edoute Y, Jungas RL, et al. Facilitating an understanding of integrative physiology: emphasis on the composition of body fluid compartments. Can J Physiol Pharmacol 2002; 80:835-850.
2. Simpson DP. Influence of plasma bicarbonate concentration and pH on citrate excretion. Am J Physiol 1964; 206:875-882.
3. Pitts RF, Lotspeich WD. Bicarbonate and the renal regulation of acid-base balance. Am J Physiol 1946; 147:138-154.
4. Moe OW, Baum M, Alpern RJ. Molecular biology of renal acid-base transporters. In: Madias N, Gennari J, Adrogué H, Galla JH, editors. Acid-base. New York: Marcel-Dekker; 2005. pp. 119-175.
5. Tew WP, Mahle C, Benavides J, et al. Synthesis and characterization of phosphocitric acid, a potent inhibitor of hydroxylapatite crystal growth. Biochemistry 1980; 19:1983-1988.
6. Rodgers A, Allie-Hamdulay S, Jackson G. Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor. Nephrol Dial Transplant 2006; 21:361-369.
7. Moe OW. Nephrolithiasis: pathophysiology and treatment. Lancet 2006; 367:333-344.
8. Pak CY. Citrate and renal calculi: an update. Miner Electrolyte Metab 1994; 20:371-377.
9. Evan AP, Lingeman JE, Coe FL, et al. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 2003; 111:607-616.
10. Moe OW, Preisig PA. Hypothesizing on the evolutionary origins of sodium-induced hypercalciuria. Curr Opin Nephrol Hyperten 2005; 14:368-372.
11. Moe OW, Huang CL. Renal mechanisms of acid-induced hypercalciuria. J Nephrology (in press).
12. Sakhaee K, Harvey JA, Padalino PK, et al. The potential role of salt abuse on the risk for kidney stone formation. J Urol 1993; 150:310-312.
13. Melnick JZ, Preisig PA, Haynes S, et al. Converting enzyme inhibition causes hypocitraturia independent of acidosis or hypokalemia. Kidney Int 1998; 54:1670-1674.
14. Amanzadeh J, Gitomer WL, Zerwekh JE, et al. Effect of high protein diet on stone-forming propensity and bone loss in rats. Kidney Int 2003; 64:2142-2149.
15. Jenkins AD, Dousa TP, Smith LH. Transport of citrate across renal brush border membrane: effects of dietary acid and alkali loading. Am J Physiol Renal Physiol 1985; 249:F590-F595.
16. Aruga S, Wehrli S, Kaissling B, et al. Chronic metabolic acidosis increases NaDC-1 mRNA and protein abundance in rat kidney. Kidney Int 2000; 58:206-215.
17. Simpson DP. Regulation of renal citrate metabolism by bicarbonate ion and pH: observations in tissue slices and mitochondria. J Clin Invest 1967; 46:225-238.
18. Melnick JZ, Srere PA, Elshourbagy NA, et al. Adenosine triphosphate citrate lyase mediates hypocitraturia in rats. J Clin Invest 1996; 98:2381-2387.
19. Melnick JZ, Preisig PA, Moe OW, et al. Renal cortical mitochondrial aconitase is regulated in hypo and hypercitraturia. Kidney Int 1998; 54:160-165.
20. Garland TJ. Conceptual and methodological issues in testing the predictions of symmorphosis. In: Weibel ER, Taylor CR, Bolis L, editors. Principles of animal design. Cambridge, UK: Cambridge University Press; 1998. pp. 40-48.
21. Gutman AB. Significance of uric acid as a nitrogenous waste in vertebrate evolution. Arthritis Rheum 1965; 8:614-626.